Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Whitehawk Therapeutics (WHWK) over the last 3 years, with Q3 2025 value amounting to $717000.0.

  • Whitehawk Therapeutics' Amortizatization of Intangibles rose 13203.88% to $717000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $879000.0, marking a year-over-year decrease of 4519.95%. This contributed to the annual value of $1.3 million for FY2024, which is 5851.4% down from last year.
  • Whitehawk Therapeutics' Amortizatization of Intangibles amounted to $717000.0 in Q3 2025, which was up 13203.88% from -$2000.0 recorded in Q2 2025.
  • In the past 5 years, Whitehawk Therapeutics' Amortizatization of Intangibles ranged from a high of $1.2 million in Q1 2023 and a low of -$19000.0 during Q1 2025
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $422000.0 (2024), whereas its average is $466636.4.
  • Over the last 5 years, Whitehawk Therapeutics' Amortizatization of Intangibles had its largest YoY gain of 13203.88% in 2025, and its largest YoY loss of 10450.24% in 2025.
  • Quarter analysis of 3 years shows Whitehawk Therapeutics' Amortizatization of Intangibles stood at $486000.0 in 2023, then plummeted by 62.35% to $183000.0 in 2024, then surged by 291.8% to $717000.0 in 2025.
  • Its Amortizatization of Intangibles was $717000.0 in Q3 2025, compared to -$2000.0 in Q2 2025 and -$19000.0 in Q1 2025.